MIT Enterprise Forum of New York City presents an evening with Samuel Waksal, founder of Imclone and CEO of Kadmon Pharmaceuticals. He will share his viewpoints on such topics as funding new biopharmaceutical ventures, the need to invigorate R&D pipelines, and key market opportunities. Register here.